The agency recommends manufacturers update their vaccines to target the JN.1 strain. At the same time, HHS head Robert F.

The new entry to FDA’s database of Recognized ... Understanding and use of product bioburden data. Three of AAMI’s most notable sterilization guidance documents were also superseded by newer ...

A Food and Drug Administration (FDA) draft guidance would require manufacturers of pulse oximeters to gather far more clinical data to show the devices accurately work across a range of skin tones.